Director adds 10,000 Healthcare Realty Trust (HR) shares in open market

Rhea-AI Filing Summary

Healthcare Realty Trust Inc director Thomas N. Bohjalian bought 10,000 shares of common stock in an open-market purchase at about $18.09 per share on March 6, 2026. After this trade, his direct holdings increased to 85,520 shares.

The purchase was executed in two tranches, with prices ranging from $18.09 to $18.10 per share.

Insider Trade Summary

Net Buyer: 10,000 shares ($180,900)

Net Buy 1 txn

Insider Bohjalian Thomas N

Role Director

Bought 10,000 shs ($181K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,000	$18.09	$181K

Holdings After Transaction: Common Stock — 85,520 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bohjalian Thomas N

(Last) (First) (Middle)

3310 WEST END AVENUE, SUITE 700

ATTENTION: ANDREW LOOPE

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Healthcare Realty Trust Inc [ HR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		P		10,000	A	$18.09(1)	85,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The trade was executed in two tranches with prices ranging from $18.09 to $18.10.

Remarks:

	/s/ Andrew E. Loope as power of attorney	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HR director Thomas N. Bohjalian report?

Thomas N. Bohjalian reported buying 10,000 shares of Healthcare Realty Trust Inc (HR) common stock. The open-market purchase occurred on March 6, 2026 at about $18.09 per share, increasing his direct ownership to 85,520 shares after the transaction.

At what price did the HR insider buy the Healthcare Realty Trust shares?

The HR insider purchase was executed around $18.09 per share. A footnote explains the trade occurred in two tranches, with prices ranging from $18.09 to $18.10, reflecting normal market execution rather than a single all-or-nothing price level.

How many Healthcare Realty Trust (HR) shares does the insider own after this trade?

Following this transaction, Thomas N. Bohjalian directly owns 85,520 shares of Healthcare Realty Trust common stock. This figure reflects his holdings immediately after buying 10,000 shares in the open market on March 6, 2026, as disclosed in the Form 4 filing.

Was the Healthcare Realty Trust (HR) insider transaction a purchase or a sale?

The reported insider transaction in Healthcare Realty Trust (HR) was a purchase. Director Thomas N. Bohjalian acquired 10,000 shares of common stock in an open-market transaction, with the Form 4 classifying the activity as a buy under transaction code P.

What does the Form 4 footnote say about the HR insider trade execution?

The Form 4 footnote states the trade was executed in two tranches with prices ranging from $18.09 to $18.10. This indicates the 10,000 shares were filled across multiple executions within a narrow price band in the open market.